Clinical trial
Evaluation of Safety, Tolerability and Immunogenicity of Two Doses of the 4CMenB Vaccine in Adults With an Immunodeficiency
NCT04295733 is registered in ClinicalTrials.gov with Ospedale Policlinico San Martino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety, Tolerability and Immunogenicity of Two Doses of the 4CMenB Vaccine in Adults With an Immunodeficiency
- Lead sponsor
- Ospedale Policlinico San Martino
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 6, 2020
- Completion date
- January 11, 2024
- Enrollment
- 98 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acquired immunodeficiency